New Executive Vice-President of Business Development and Director of MerckInvents@ TEC Edmonton also announced
Edmonton, AB (April 24, 2018) – This month, TEC Edmonton welcomes Wayne Karpoff as the new Chair of TEC Edmonton’s Board of Directors. A TEC Edmonton board member since 2006, Wayne is a longtime leader in Edmonton’s business community and is the President and CEO of Willowglen Systems, an Edmonton-based company that develops automation solutions for many industries worldwide, including oil & gas, power, transportation and water.
Wayne has over 30 years of corporate experience as an entrepreneur in the advanced technology sector and a long track record of building businesses to become technology leaders. Before becoming CEO of Willowglen, Wayne founded the Edmonton-based data storage startup YottaYotta, which was acquired by EMC (now DELLEMC) to create the VPLex product line. Prior to founding YottaYotta, Wayne joined the technology startup Myrias Research Corporation, a Canadian supercomputer entry where he took the company out of receivership and ran it as president. Wayne has significant management experience in all aspects of creating high-growth technology companies.
“Wayne is a strong believer that entrepreneurialism includes developing and supporting the community,” said TEC Edmonton CEO Chris Lumb. “Nothing demonstrates this more than his service to TEC Edmonton as a founding board member and now board chair. Wayne is a motivating force to those around him and TEC Edmonton will surely benefit from his leadership.”
Additional staff announcements:
Darrell Petras, Executive Vice-President of Business Development. Through strategic partnerships and a team of experienced entrepreneurial advisors, Darrell is responsible for pursuing business development and commercialization opportunities so companies can grow their businesses successfully.
Ryan Heit, Director, Merck Invention Accelerator. Ryan will lead this inaugural program and collaboration between TEC Edmonton and Merck Research Labs. The business accelerator aims to advance the success of emerging health technologies to save and improve lives globally.
About TEC Edmonton TEC Edmonton is a business accelerator that helps emerging technology companies grow successfully. As a joint venture of the University of Alberta and Edmonton Economic Development Corporation, TEC Edmonton operates the Edmonton region’s largest accelerator for early-stage technology companies and manages commercialization of University of Alberta technologies. TEC Edmonton delivers services in four areas: Business Development, Funding and Finance, Technology Management, and Entrepreneur Development.
Since 2011, TEC clients have generated $915M in revenue, raised $444M in financing and funding, invested 246M in R&D, and grown both revenue and employment by 20 per cent per year and now employ over 1,900 people in the region. TEC has assisted in the creation of 27 spin-off companies from the University of Alberta in the last six years.
TEC Edmonton was named the 3rd best University Business Accelerator in the world by the University Business Incubator (UBI) Global Index in 2018. For more information, visit TECEdmonton.com.
There’s a new lab space in the downtown Edmonton innovation corridor: introducing TEC Centre Labs, a nearly 8,000 square foot collaboration, office and wet lab space for health companies and researchers. Officially opening later this spring, TEC Centre Labs will become home to two accelerator programs:
Merck Invention Accelerator
The first partnership of its kind for Merck, this accelerator has a goal to advance the success of emerging health technologies to save and improve lives around the world. Health sciences entrepreneurs and early-stage pharmaceutical or health technology companies can access personalized input from Merck and TEC Edmonton experts to develop novel scientific innovations. Eligible entrepreneurs and companies can learn more and apply to be a part of the inaugural cohort here.
University of Alberta Health Accelerator
The University of Alberta (UAlberta) Health Accelerator was created to support and inspire professional, entrepreneurial and commercial activities within the health sciences. The program has two streams: Primary Investigator/Researcher stream that focuses on identifying and advancing early-stage commercial opportunities from UAlberta research, and the Trainee stream that trains the next generation of innovators by providing UAlberta graduate and postgraduate learners professional development opportunities in business, innovation and entrepreneurship.
Since both programs will operate out of TEC Centre Labs, participants in each program will benefit from world-class laboratory space, in addition to collaboration opportunities with other innovators in the health technology sector.
TEC Centre Labs will officially open in Summer 2018 – stay tuned for more details!
A Novel Method to Produce Pitched Kefir for Reducing Cholesterol
Description Researchers at the University of Alberta and TEAGASC have jointly developed a pitched-based method to produce kefir (a fermented milk beverage) that when consumed reduces blood cholesterol levels. The......
Novel F-18 Beta-Hydroxybutyric Acid Radiotracers for PET Imaging
Description Researchers at the University of Alberta have synthesized novel beta-hydroxybutyric acid radiotracers for PET imaging using a 3 step radiosynthetic process. The compounds are designed to serve as radiofluorinated......
A Novel Method for CryoPreservation of Cells in Monolayers
Description Researchers at the University of Alberta have developed a novel method to cryopreserve cells while adhered in a monolayer configuration. This method can preserve cells on a substrate and......
Train-Triggered Alert System for Conditioning and Warning Wildlife
Description Researchers at the University of Alberta have developed a novel, inexpensive, and compact system to alert wildlife to approaching trains, increasing the time available to avoid a collision. Rail-caused......
Description Dr. Afsaneh Lavasanifar and collaborators have developed a PCBCL–b-PEG-b-PCBCL (PolyGelTM) hydrogel formulation of silibinin which provides enhanced skin permeabiity and delayed release of silibinin under physiological conditions. In vitro......
Novel FOXM-1 inhibitors for diagnosis and treatment of cancer
Description Researchers at the University of Alberta are utilizing their new insights into the mechanism of action of FOXM-1 inhibitors to design first in class oncology drugs targeting FOXM-1 protein.......
Novel SERS-Based Biosensing platform for prostate cancer
Description Researchers at the University of Alberta have developed biogenic silver nanoparticles which can be used as plasmonic labels for enhanced spectroscopy applications. The nanoparticles can be modified with Raman......
Hand-Held Device and Computer-Implemented Steering of a Percutaneously Inserted Needle
Description Dr. Mahdi Tavakoli and his team at the University of Alberta have developed a novel hand-held device and methods to enable real-time assisted steering of percutaneously inserted needles, such as......
Novel Radiation-Responsive Nanoparticles for Biomedical Applications
Description Researchers at the University of Alberta in collaboration with Lakehead University have developed novel radiation-responsive block polymers for drug delivery. The nanoparticles are modified poly-L-glutamic acid (m-PGA) polymers which......
Flow Cytometry Sensing Using Diffracted Orders of a Grating
Description Flow cytometry is a useful tool that employed in diagnoses of various blood diseases, basic research, clinical trials or even as a “cell sorter” instrument. Currently, flow cytometry involves......
Off-Axis Spiral Phase Mirrors To Create Vortex Beams
Description There has been an increased interest in taking advantage of the orbital angular momentum properties of light via helical wavefronts for various applications in manufacturing, imaging, and communications. By......